HighTower Advisors
LEGN icon

HighTower Advisors’s Legend Biotech LEGN Stock Holding History

HighTower Advisors’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,197
Closed -$346K – 3881
2025
Q1 		$346K Buy
10,197
+118
+1% +$4.23K ﹤0.01% 2747
2024
Q4 		$328K Buy
10,079
+4,325
+75% +$179K ﹤0.01% 2822
2024
Q3 		$278K Sell
5,754
-99
-2% -$5.27K ﹤0.01% 2865
2024
Q2 		$260K Buy
+5,853
New +$270K ﹤0.01% 2831

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

HighTower Advisors's LEGN Position: Q2 2025 in Review

HighTower Advisors sold out of Legend Biotech (LEGN) in Q2 2025, closing a stake of 10,197 shares — an estimated $346K sold.

HighTower Advisors first reported a position in LEGN in Q2 2024 and held it in 4 quarters. The position peaked at $346K in Q1 2025. 211 funds tracked by Wall St. Rank hold LEGN as of Q2 2025.

  • HighTower Advisors reported no remaining Legend Biotech position as of Q2 2025 after selling out during the quarter.
  • HighTower Advisors sold 10,197 Legend Biotech shares in Q2 2025, an estimated $346K.
  • HighTower Advisors first reported a position in Legend Biotech in Q2 2024 and held it in 4 quarters.
  • HighTower Advisors's Legend Biotech position peaked at $346K in Q1 2025.
  • 211 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2025.

Based on HighTower Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.